Ocular Toxicity in Breast Cancer Management: Manual for The Oncologist-Reference-Cited by-同舟云学术

Ocular Toxicity in Breast Cancer Management: Manual for The Oncologist

Published:2022-06 Issue:4 Volume:22 Page:289-299
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Canino Fabio^ORCID,Omarini Claudia^ORCID,Cerma Krisida,Moscetti Luca^ORCID,Tornincasa Antonio^ORCID,Trudu Lucia,Dominici Massimo,Piacentini Federico^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference77 articles.

1. Ophthalmic toxicity during carboplatin therapy;Rankin;Ann Oncol,1993

2. Blindness associated with high-dose carboplatin;O'Brien;Lancet,1992

3. Ocular toxicity of antineoplastic agents;Fraunfelder;Ophthalmology,1983

4. Blurring of vision: a previously undescribed complication of cyclophosphamide therapy;Kende;Cancer,1979

5. Ocular surface and tear film abnormalities in women under adjuvant chemotherapy for breast cancer with the 5-Fluorouracil, Epirubicin and Cyclophosphamide (FEC) regimen;Karamitsos;Hippokratia,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor–Positive Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: Primary Results From TROPION-Breast01;Journal of Clinical Oncology;2024-09-12

2. Inflammatory keratitis and trastuzumab in the context of breast cancer - a case report;2024-08-26

3. Patient-reported outcomes and symptom clusters pattern of chemotherapy-induced toxicity in patients with early breast cancer;PLOS ONE;2024-02-23

4. HER2-Directed Therapy in Advanced Breast Cancer: Benefits and Risks;OncoTargets and Therapy;2023-02

5. Relationship between tamoxifen and cataracts: a nationwide cohort study of women in South Korea;Breast Cancer Research and Treatment;2022-12-10